Triangle startup Pairwise strikes genome editing deal with MIT-Harvard institute

Posted by on Mar 20, 2019 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – Pairwise, one of the Triangle area’s fast-growing agriculture and food biotech companies, has licensed some advanced CRISPR genome editing technologies from two prestigious Boston institutions to expand its crop-editing applications and bring new foods to market. Pairwise, which operates a site in Durham’s Golden Belt and greenhouses in Research Triangle Park, has entered into licensing agreements with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard (Broad Institute) for their latest CRISPR genome editing...

Read More

Virginia Bio CEO Jeff Gallagher Stepping Down

Posted by on Mar 19, 2019 in Newsroom | 0 comments

RICHMOND, VA. – Virginia Bio, the statewide non-profit trade association for the life science industry, announced today that after seven years of service Jeff Gallagher CEO will step down from his position as CEO later this year, then will continue to serve the association on select special projects. A national search for a new CEO will begin immediately, conducted by the Virginia Bio Board of Directors. Under Mr. Gallagher’s leadership, Virginia Bio has prioritized service to its many members, built important new collaborations, woven together the state’s diverse and dynamic...

Read More

vTv Therapeutics Announces $15 Million of Class A Common Stock Financings

Posted by on Mar 19, 2019 in Newsroom | 0 comments

HIGH POINT, N.C. – -vTv Therapeutics Inc. (Nasdaq:VTVT) (the “Company”) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered direct offering (the “Registered Direct Offering”) of 3,636,364 shares of the Company’s Class A common stock (the “Common Stock”) at a price of $1.65 per share for aggregate gross proceeds of approximately $6.0 million. The offering is expected to close on or about March 20, 2019, subject to the satisfaction of customary closing conditions. H.C. Wainwright...

Read More

Advantage Capital Invests $6.5 Million in Danimer Scientific, Supporting Company’s Growth in Rural Georgia

Posted by on Mar 19, 2019 in Newsroom | 0 comments

NEW ORLEANS, LA. & BAINBRIDGE, GA. – Advantage Capital today announced a $6.5 million investment in Danimer Scientific, a leading biotechnology company producing biodegradable and compostable polymers used in consumer and industrial products. The investment was made through the GARJA program and supports the company’s anticipated growth as it seeks to boost capacity and significantly increase its workforce at its Bainbridge, GA location over the next few years. “The Georgia Agribusiness and Rural Jobs Act was created to bring investment capital and jobs to the more rural parts...

Read More

Cresco Labs Enters Florida

Posted by on Mar 19, 2019 in Newsroom | 0 comments

CHICAGO, IL. & JACKSONVILLE, FL. – Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it is entering the Florida market through the signing of a letter agreement to acquire the ownership interests or assets of VidaCann Ltd. and/or affiliated entities (“VidaCann”), one of the largest and most advanced providers of medical cannabis in Florida (the “Transaction”). Key Transaction Highlights and Benefits: Vertically Integrated...

Read More